Literature DB >> 17686802

Monocyte toll-like receptor 2 and 4 responses and expression following percutaneous coronary intervention: association with lesion stenosis and fractional flow reserve.

D Versteeg1, I E Hoefer, A H Schoneveld, D P V de Kleijn, E Busser, C Strijder, M Emons, P R Stella, P A Doevendans, G Pasterkamp.   

Abstract

BACKGROUND: Toll-like receptors (TLRs) are key players in innate immunity and are causally related to arterial occlusive disease and arterial remodelling. The release of proinflammatory cytokines following TLR ligand binding is increased in patients with unstable angina.
OBJECTIVE: To examine the effect of a percutaneous coronary intervention (PCI) on TLR2 and TLR4 response and expression.
METHODS: In 70 PCI patients, blood samples were gathered after sheath insertion and 2 hours after the catheterisation. TLR2 and TLR4 expression on, and tumour necrosis factor alpha (TNFalpha) levels in, monocytes were measured with flow cytometry. Whole blood was stimulated overnight with the TLR2 ligand Pam3Cys and the TLR4 ligand lipopolysaccharide. TNFalpha was determined in the stimulated samples and considered to be a measure of the TLR response. Baseline TLR expression and response were studied in relation to angiographic luminal stenosis and fractional flow reserve (FFR) measurement.
RESULTS: A significant relation was found between TLR response and the angiographic percentage diameter stenosis, number of diseased vessels and FFR outcome. Furthermore, 2 hours after PCI a significant decrease in TLR2 and TLR4 response (p<0.001) and TLR2 and TLR4 expression (p = 0.001 and p = 0.068, respectively) was seen.
CONCLUSION: TLR response is positively associated with percentage diameter stenosis, multivessel disease and FFR outcome. Systemic TLR2 and TLR4 response and expression decrease after PCI. These results suggests that the TLR signalling pathway encompasses a potential biomarker for myocardial ischaemia in stable coronary artery disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17686802     DOI: 10.1136/hrt.2007.117259

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  17 in total

Review 1.  Comprehensive plaque assessment by coronary CT angiography.

Authors:  Pál Maurovich-Horvat; Maros Ferencik; Szilard Voros; Béla Merkely; Udo Hoffmann
Journal:  Nat Rev Cardiol       Date:  2014-04-22       Impact factor: 32.419

2.  Influence of plaque characteristics on fractional flow reserve for coronary lesions with intermediate to obstructive stenosis: insights from integrated-backscatter intravascular ultrasound analysis.

Authors:  Shinichiro Sakurai; Hiroaki Takashima; Katsuhisa Waseda; Masahiko Gosho; Akiyoshi Kurita; Hirohiko Ando; Kazuyuki Maeda; Akihiro Suzuki; Masanobu Fujimoto; Tetsuya Amano
Journal:  Int J Cardiovasc Imaging       Date:  2015-07-01       Impact factor: 2.357

Review 3.  Are toll-like receptors potential drug targets for atherosclerosis? Evidence from genetic studies to date.

Authors:  Christopher P Nelson; Clett Erridge
Journal:  Immunogenetics       Date:  2018-10-16       Impact factor: 2.846

Review 4.  The expression and functions of toll-like receptors in atherosclerosis.

Authors:  Jennifer E Cole; Ektoras Georgiou; Claudia Monaco
Journal:  Mediators Inflamm       Date:  2010-06-24       Impact factor: 4.711

Review 5.  CT Imaging of the Vulnerable Plaque.

Authors:  Gary R Small; Benjamin J W Chow
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-11-06

6.  Hydrocortisone reduces Toll-like receptor 4 expression on peripheral CD14+ monocytes in patients undergoing percutaneous coronary intervention.

Authors:  Bahador Bagheri; Bahram Sohrabi; Ali Akbar Movassaghpour; Simin Mashayekhi; Afagh Garjani; Mehriar Shokri; Masoud Pezeshkian; Alireza Garjani
Journal:  Iran Biomed J       Date:  2014

7.  Everolimus-Eluting Stents Reduce Monocyte Expression of Toll-Like Receptor 4.

Authors:  Mehriar Shokri; Bahador Bagheri; Alireza Garjani; Bahram Sohrabi; Afshin Habibzadeh; Babak Kazemi; Ali Akbar Movassaghpour
Journal:  Adv Pharm Bull       Date:  2015-12-31

8.  Innate immunity and monocyte-macrophage activation in atherosclerosis.

Authors:  Joseph Shalhoub; Mika A Falck-Hansen; Alun H Davies; Claudia Monaco
Journal:  J Inflamm (Lond)       Date:  2011-04-28       Impact factor: 4.981

9.  Activated TLR signaling in atherosclerosis among women with lower Framingham risk score: the multi-ethnic study of atherosclerosis.

Authors:  Chiang-Ching Huang; Kiang Liu; Richard M Pope; Pan Du; Simon Lin; Nalini M Rajamannan; Qi-Quan Huang; Nadereh Jafari; Gregory L Burke; Wendy Post; Karol E Watson; Craig Johnson; Martha L Daviglus; Donald M Lloyd-Jones
Journal:  PLoS One       Date:  2011-06-16       Impact factor: 3.240

10.  Toll-Like Receptor induced CD11b and L-selectin response in patients with coronary artery disease.

Authors:  Ellen H A M Elsenberg; Marieke A Hillaert; Hester M den Ruijter; Jan-Willem E M Sels; Vincent P W Scholtes; Hendrik M Nathoe; Johan Kuiper; J Wouter Jukema; Pieter A Doevendans; Gerard Pasterkamp; Imo E Hoefer
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.